Literature DB >> 19896518

Effect of human leukocyte antigen homozygosity on rubella vaccine-induced humoral and cell-mediated immune responses.

Richard B Kennedy1, Inna G Ovsyannikova, Robert A Vierkant, Robert M Jacobson, Gregory A Poland.   

Abstract

Human leukocyte antigen (HLA) genes play a critical role in host immunity, including vaccine responses. HLA molecules present antigenic peptides to T cells and provide inhibitory signals to NK cells, and polymorphisms within HLA genes allow binding and presentation of a diverse array of self and foreign peptides. Heterozygosity across HLA alleles has been found to play a positive role in host defense for a variety of infections. Homozygosity within one or more HLA loci may restrict this epitope repertoire and limit T-cell responses to infection or vaccination. Here we report that homozygosity within the HLA DPB1 locus is associated with increased levels of rubella-specific IgG, an effect driven by a common allele DPB1*0401. We also show that homozygosity within different HLA class I and class II loci is correlated with variations (but not necessarily decreases) in interleukin (IL)-2, IL-5, and IL-10 secretion after rubella virus stimulation. Copyright 2010 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19896518      PMCID: PMC2815167          DOI: 10.1016/j.humimm.2009.11.002

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  32 in total

Review 1.  Viral immune evasion: a masterpiece of evolution.

Authors:  Mireille T M Vossen; Ellen M Westerhout; Cécilia Söderberg-Nauclér; Emmanuel J H J Wiertz
Journal:  Immunogenetics       Date:  2002-10-24       Impact factor: 2.846

2.  Rubella antibody persistence after immunization. Sixteen-year follow-up in the Hawaiian Islands.

Authors:  S Y Chu; R H Bernier; J A Stewart; K L Herrmann; J R Greenspan; A K Henderson; A P Liang
Journal:  JAMA       Date:  1988-06-03       Impact factor: 56.272

3.  Genetic variability and linkage disequilibrium within the HLA-DP region: analysis of 15 different populations.

Authors:  A B Begovich; P V Moonsamy; S J Mack; L F Barcellos; L L Steiner; S Grams; V Suraj-Baker; J Hollenbach; E Trachtenberg; L Louie; P Zimmerman; A V Hill; M Stoneking; T Sasazuki; V I Konenkov; M L Sartakova; V P Titanji; O Rickards; W Klitz
Journal:  Tissue Antigens       Date:  2001-05

4.  Measles, mumps, and rubella antibodies in children 5-6 years after immunization: effect of vaccine type and age at vaccination.

Authors:  N Boulianne; G De Serres; S Ratnam; B J Ward; J R Joly; B Duval
Journal:  Vaccine       Date:  1995-11       Impact factor: 3.641

5.  Clinical and laboratory studies of combined live measles, mumps, and rubella vaccines using the RA 27/3 rubella virus.

Authors:  R E Weibel; A J Carlson; V M Villarejos; E B Buynak; A A McLean; M R Hilleman
Journal:  Proc Soc Exp Biol Med       Date:  1980-11

6.  Associations between human leukocyte antigen homozygosity and antibody levels to measles vaccine.

Authors:  Jennifer L St Sauver; Inna G Ovsyannikova; Robert M Jacobson; Steven J Jacobsen; Robert A Vierkant; Daniel J Schaid; V Shane Pankratz; Erin M Green; Gregory A Poland
Journal:  J Infect Dis       Date:  2002-05-09       Impact factor: 5.226

7.  Infectious complications in sickle cell disease are influenced by HLA class II alleles.

Authors:  Ryad Tamouza; Maria Grazia Neonato; Marc Busson; François Marzais; Robert Girot; Dominique Labie; Jacques Elion; Dominique Charron
Journal:  Hum Immunol       Date:  2002-03       Impact factor: 2.850

8.  Persistence of rubella antibodies 15 years after subcutaneous administration of Wistar 27/3 strain live attenuated rubella virus vaccine.

Authors:  I B Hillary; A H Griffith
Journal:  Vaccine       Date:  1984-12       Impact factor: 3.641

9.  Immune response to measles, mumps & rubella vaccine at 9, 12 & 15 months of age.

Authors:  R Singh; T J John; T Cherian; P Raghupathy
Journal:  Indian J Med Res       Date:  1994-10       Impact factor: 2.375

10.  Advantage of rare HLA supertype in HIV disease progression.

Authors:  Elizabeth Trachtenberg; Bette Korber; Cristina Sollars; Thomas B Kepler; Peter T Hraber; Elizabeth Hayes; Robert Funkhouser; Michael Fugate; James Theiler; Yen S Hsu; Kevin Kunstman; Samuel Wu; John Phair; Henry Erlich; Steven Wolinsky
Journal:  Nat Med       Date:  2003-07       Impact factor: 53.440

View more
  10 in total

Review 1.  Vaccinomics and a new paradigm for the development of preventive vaccines against viral infections.

Authors:  Gregory A Poland; Inna G Ovsyannikova; Richard B Kennedy; Iana H Haralambieva; Robert M Jacobson
Journal:  OMICS       Date:  2011-07-06

Review 2.  Methodological aspects of anti-human leukocyte antigen antibody analysis in solid organ transplantation.

Authors:  Andrew L Lobashevsky
Journal:  World J Transplant       Date:  2014-09-24

3.  Polymorphisms in the Wilms Tumor Gene Are Associated With Interindividual Variations in Rubella Virus-Specific Cellular Immunity After Measles-Mumps-Rubella II Vaccination.

Authors:  Emily A Voigt; Iana H Haralambieva; Beth L Larrabee; Richard B Kennedy; Inna G Ovsyannikova; Daniel J Schaid; Gregory A Poland
Journal:  J Infect Dis       Date:  2018-01-30       Impact factor: 5.226

4.  Polymorphisms in HLA-DPB1 are associated with differences in rubella virus-specific humoral immunity after vaccination.

Authors:  Nathaniel D Lambert; Iana H Haralambieva; Richard B Kennedy; Inna G Ovsyannikova; Vernon Shane Pankratz; Gregory A Poland
Journal:  J Infect Dis       Date:  2014-10-06       Impact factor: 5.226

5.  Genome-wide SNP associations with rubella-specific cytokine responses in measles-mumps-rubella vaccine recipients.

Authors:  Richard B Kennedy; Inna G Ovsyannikova; Iana H Haralambieva; Nathaniel D Lambert; V Shane Pankratz; Gregory A Poland
Journal:  Immunogenetics       Date:  2014-05-09       Impact factor: 2.846

6.  Genetic polymorphisms associated with rubella virus-specific cellular immunity following MMR vaccination.

Authors:  Richard B Kennedy; Inna G Ovsyannikova; Iana H Haralambieva; Nathaniel D Lambert; V Shane Pankratz; Gregory A Poland
Journal:  Hum Genet       Date:  2014-08-07       Impact factor: 4.132

7.  Human leukocyte antigens and cellular immune responses to anthrax vaccine adsorbed.

Authors:  Inna G Ovsyannikova; V Shane Pankratz; Robert A Vierkant; Nicholas M Pajewski; Conrad P Quinn; Richard A Kaslow; Robert M Jacobson; Gregory A Poland
Journal:  Infect Immun       Date:  2013-05-06       Impact factor: 3.441

8.  HLA genotypes and rubella vaccine immune response: additional evidence.

Authors:  Inna G Ovsyannikova; V Shane Pankratz; Beth R Larrabee; Robert M Jacobson; Gregory A Poland
Journal:  Vaccine       Date:  2014-05-15       Impact factor: 3.641

Review 9.  Rubella.

Authors:  Nathaniel Lambert; Peter Strebel; Walter Orenstein; Joseph Icenogle; Gregory A Poland
Journal:  Lancet       Date:  2015-01-08       Impact factor: 79.321

10.  Associations between SNPs in candidate immune-relevant genes and rubella antibody levels: a multigenic assessment.

Authors:  V Shane Pankratz; Robert A Vierkant; Megan M O'Byrne; Inna G Ovsyannikova; Gregory A Poland
Journal:  BMC Immunol       Date:  2010-10-05       Impact factor: 3.615

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.